Lifespan of Untreated Nephrotic Syndrome
Untreated nephrotic syndrome carries a grave prognosis with dramatically shortened lifespan, particularly dependent on the underlying histologic type and age of onset—with congenital forms having a mean survival of only 7.6 months (range 0-26 months) when untreated, and FSGS progressing to end-stage renal disease in more than 50% of patients within 5-10 years.
Age-Specific Prognosis
Congenital Nephrotic Syndrome (CNS)
The most severe outcomes occur in untreated congenital cases. Historical data from Finland (1965-1973) demonstrated that untreated CNS patients had a mean survival of 7.6 months with a range of 0-26 months 1. The primary causes of death were:
- Infection (most common)
- Haemodynamic collapse
- Thrombotic complications
Most children with CNS progress to kidney failure within a few years even with supportive care 1.
Focal Segmental Glomerulosclerosis (FSGS)
If untreated, more than 50% of patients with persistent nephrotic syndrome will progress to ESRD within 5-10 years 2. The prognosis is particularly poor because:
- Spontaneous remission occurs in less than 6% of cases 2
- Remission of proteinuria is the only significant predictor of renal survival 2
- Without treatment to achieve remission, progressive kidney scarring is inevitable
Recent data shows 10-year kidney survival in untreated/unresponsive FSGS is approximately 37% when proteinuria remains >3.5 g/g 3.
Membranous Nephropathy
Patients with longstanding untreated nephrotic syndrome from membranous nephropathy face significantly shortened life expectancy. Those with persistent nephrotic syndrome for more than 2 years had a ratio of observed to expected death of 4.76 (95% CI: 2.05-9.37), meaning they were nearly 5 times more likely to die than age-matched controls 4. The actual lifespan was shortened by approximately 30 years compared to life expectancy 4.
Minimal Change Disease (MCD)
While MCD generally has better outcomes than FSGS, untreated disease still carries significant mortality risk. In children with MCD who failed to respond to initial treatment, nearly one-fifth of initial non-responders died 5. The 10-year kidney survival for MCD patients with persistent nephrotic-range proteinuria (>3.5 g/g) is approximately 64% 3.
Mechanisms of Mortality and Morbidity
Direct Complications
Untreated nephrotic syndrome causes death through multiple mechanisms 2:
Thromboembolism:
- Renal vein thrombosis: 29% prevalence
- Pulmonary embolism: 17-28% prevalence
- Deep vein thrombosis: 11% prevalence
Infections:
- Cellulitis and spontaneous bacterial peritonitis (especially in children)
- Pneumonia
- Sepsis due to immunoglobulin loss
Cardiovascular disease:
- Risk of coronary heart disease is 4 times greater than age-matched controls 2
- Accelerated atherosclerosis from hypercholesterolemia, hypertension, and hypercoagulability
Progressive Kidney Failure
Patients with proteinuria >3.8 g/day have a 35% risk of ESRD within 2 years, compared to only 4% risk for those with proteinuria <2.0 g/day 2. The duration and severity of proteinuria directly correlate with progression to renal scarring and eventual kidney failure.
Hypoalbuminemia Effects
Each 1.0 g/dL decrease in serum albumin increases the odds of morbidity by 89% and mortality by 137% 2. This reflects the systemic impact of severe protein loss on overall health status.
Critical Caveats
The prognosis varies dramatically based on:
- Histologic subtype: Genetic/congenital forms have the worst prognosis, followed by FSGS, then membranous nephropathy, with MCD having relatively better outcomes
- Age at onset: Congenital and early childhood onset carries higher mortality
- Severity of proteinuria: Higher levels predict worse outcomes across all subtypes
- Presence of complications: Infection, thrombosis, and cardiovascular events dramatically worsen survival
Modern context: The historical data on untreated disease comes primarily from the 1960s-1970s era. Even with contemporary supportive care (albumin infusions, diuretics, infection prophylaxis, anticoagulation) but without immunosuppressive therapy, outcomes remain poor, though likely somewhat better than the historical untreated cohorts 1.
The stark difference in outcomes between treated and untreated disease underscores why treatment should never be withheld when nephrotic syndrome is diagnosed, as the natural history without intervention is progression to kidney failure and premature death in the majority of cases.